Literature DB >> 16715367

Hepatic CYP3A expression is attenuated in obese mice fed a high-fat diet.

Kouichi Yoshinari1, Shunsuke Takagi, Teruyasu Yoshimasa, Junko Sugatani, Masao Miwa.   

Abstract

PURPOSE: Changes in physiological, pathophysiological, and/or nutritional conditions often alter the expression of drug-metabolizing enzymes. In this study, we investigated obesity-induced changes in hepatic cytochrome P450 (P450) levels using nutritionally obese mice.
METHODS: To induce obesity, mice were fed a high-fat diet or treated with gold thioglucose, which impairs ventromedial hypothalamus. Total RNAs and microsomal and nuclear proteins were prepared from the liver of these mice, and mRNA and protein levels of P450s and transcription factors were determined.
RESULTS: Among P450s examined, the constitutive expression of CYP3As was drastically reduced at both mRNA and protein levels by nutrition-induced obesity. One-week administration of a high-fat diet also reduced hepatic CYP3As. However, changes in nuclear receptors involved in the transcriptional regulation of CYP3A genes were not correlated with that of CYP3As. Obese mice induced by gold thioglucose exhibited a different expression profile of hepatic P450s with no significant change in CYP3As.
CONCLUSION: High-fat diet-induced changes in energy metabolism, which eventually result in obesity, modulate the hepatic expression profile of P450s, particularly CYP3As. Alternatively, the accumulation of a certain component in a high-fat diet may directly attenuate the CYP3A expression, suggesting a clinically important drug-diet interaction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715367     DOI: 10.1007/s11095-006-0071-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  38 in total

1.  Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.

Authors:  Junko Sugatani; Kasumi Yamakawa; Kouich Yoshinari; Takashi Machida; Hitoshi Takagi; Masatomo Mori; Satoru Kakizaki; Tatsuya Sueyoshi; Masahiko Negishi; Masao Miwa
Journal:  Biochem Biophys Res Commun       Date:  2002-03-29       Impact factor: 3.575

2.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

3.  Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation.

Authors:  I Leclercq; Y Horsmans; J P Desager; N Delzenne; A P Geubel
Journal:  J Hepatol       Date:  1998-03       Impact factor: 25.083

4.  Nuclear receptor CAR as a regulatory factor for the sexually dimorphic induction of CYB2B1 gene by phenobarbital in rat livers.

Authors:  K Yoshinari; T Sueyoshi; R Moore; M Negishi
Journal:  Mol Pharmacol       Date:  2001-02       Impact factor: 4.436

5.  Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion.

Authors:  B Vozarova; C Weyer; K Hanson; P A Tataranni; C Bogardus; R E Pratley
Journal:  Obes Res       Date:  2001-07

6.  Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin.

Authors:  Po-Yung Cheng; Molin Wang; Edward T Morgan
Journal:  J Pharmacol Exp Ther       Date:  2003-10-13       Impact factor: 4.030

7.  The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4.

Authors:  Rommel G Tirona; Wooin Lee; Brenda F Leake; Lu-Bin Lan; Cynthia Brimer Cline; Vishal Lamba; Fereshteh Parviz; Stephen A Duncan; Yusuke Inoue; Frank J Gonzalez; Erin G Schuetz; Richard B Kim
Journal:  Nat Med       Date:  2003-01-06       Impact factor: 53.440

8.  Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver.

Authors:  E T Morgan; K B Thomas; R Swanson; T Vales; J Hwang; K Wright
Journal:  Biochim Biophys Acta       Date:  1994-10-18

9.  Expression and induction of cytochromes p450 in rat white adipose tissue.

Authors:  Kouichi Yoshinari; Takeshi Sato; Nao Okino; Junko Sugatani; Masao Miwa
Journal:  J Pharmacol Exp Ther       Date:  2004-05-18       Impact factor: 4.030

10.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

View more
  20 in total

1.  Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters.

Authors:  Romi Ghose; Ozozoma Omoluabi; Adarsh Gandhi; Pranav Shah; Kelley Strohacker; Katie C Carpenter; Brian McFarlin; Tao Guo
Journal:  Life Sci       Date:  2011-05-18       Impact factor: 5.037

2.  Relative hepatic weight using body weight may be not accurate.

Authors:  Xiu-Juan Yang
Journal:  World J Pediatr       Date:  2017-04       Impact factor: 2.764

3.  Relative hepatic weight using body weight may be not accurate.

Authors:  Shao-Qing Ni
Journal:  World J Pediatr       Date:  2017-04       Impact factor: 2.764

4.  High-Fat Diet Feeding Alters Expression of Hepatic Drug-Metabolizing Enzymes in Mice.

Authors:  Miaoran Ning; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2017-04-25       Impact factor: 3.922

5.  Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteers.

Authors:  Margreke J E Brill; Anne van Rongen; Aletta P I Houwink; Jacobus Burggraaf; Bert van Ramshorst; René J Wiezer; Eric P A van Dongen; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

Review 6.  Drug disposition in pathophysiological conditions.

Authors:  Adarsh Gandhi; Bhagavatula Moorthy; Romi Ghose
Journal:  Curr Drug Metab       Date:  2012-11       Impact factor: 3.731

7.  Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism.

Authors:  Katherine N Theken; Yangmei Deng; Robert N Schuck; Akinyemi Oni-Orisan; Tricia M Miller; M Alison Kannon; Samuel M Poloyac; Craig R Lee
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-12-20       Impact factor: 4.310

8.  The effect of bamboo extract on hepatic biotransforming enzymes--findings from an obese-diabetic mouse model.

Authors:  Cheryl L K Koide; Abby C Collier; Marla J Berry; Jun Panee
Journal:  J Ethnopharmacol       Date:  2010-09-09       Impact factor: 4.360

9.  Diet-induced obesity alters vincristine pharmacokinetics in blood and tissues of mice.

Authors:  James W Behan; Vassilios I Avramis; Jason P Yun; Stan G Louie; Steven D Mittelman
Journal:  Pharmacol Res       Date:  2010-01-18       Impact factor: 7.658

10.  Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity.

Authors:  Alison B Edelman; Nichole E Carlson; Ganesh Cherala; Myrna Y Munar; Richard L Stouffer; Judy L Cameron; Frank Z Stanczyk; Jeffrey T Jensen
Journal:  Contraception       Date:  2009-06-04       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.